La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Prothena Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Gene Kinney
Amministratore delegato
US$7.0m
Compenso totale
| Percentuale dello stipendio del CEO | 9.0% |
| Mandato del CEO | 8yrs |
| Proprietà del CEO | 0.02% |
| Durata media del management | 7.5yrs |
| Durata media del Consiglio di amministrazione | 5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares
Jul 26
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Jun 19Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials
Jun 07New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)
May 14Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
Feb 23Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%
Feb 08Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?
Dec 20Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business
Nov 24Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk
Oct 27Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Aug 25What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today
May 10We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth
Apr 23Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook
Mar 01We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
Dec 28Prothena: Paying A Premium To Cover All The Alzheimer's Bases
Sep 29Prothena GAAP EPS of -$0.88 misses by $0.31
Aug 08Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates
May 08Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$172m |
| Dec 31 2023 | US$7m | US$631k | -US$147m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$141m |
| Mar 31 2023 | n/a | n/a | -US$128m |
| Dec 31 2022 | US$7m | US$601k | -US$117m |
| Sep 30 2022 | n/a | n/a | -US$156m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | n/a | n/a | US$67m |
| Dec 31 2021 | US$5m | US$573k | US$67m |
| Sep 30 2021 | n/a | n/a | US$69m |
| Jun 30 2021 | n/a | n/a | -US$70m |
| Mar 31 2021 | n/a | n/a | -US$124m |
| Dec 31 2020 | US$3m | US$554k | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$80m |
| Dec 31 2019 | US$3m | US$538k | -US$78m |
| Sep 30 2019 | n/a | n/a | -US$79m |
| Jun 30 2019 | n/a | n/a | -US$84m |
| Mar 31 2019 | n/a | n/a | -US$128m |
| Dec 31 2018 | US$11m | US$525k | -US$156m |
| Sep 30 2018 | n/a | n/a | -US$181m |
| Jun 30 2018 | n/a | n/a | -US$209m |
| Mar 31 2018 | n/a | n/a | -US$167m |
| Dec 31 2017 | US$5m | US$521k | -US$153m |
Compensazione vs Mercato: La retribuzione totale di Gene ($USD 7.04M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 3.30M ).
Compensazione vs guadagni: La retribuzione di Gene è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Gene Kinney (55 yo)
8yrs
Mandato
US$7,043,826
Compensazione
Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 8yrs | US$7.04m | 0.024% $ 256.5k | |
| CFO & Chief Strategy Officer | 11.5yrs | US$2.70m | 0.0060% $ 64.2k | |
| Chief Operating Officer | 2.9yrs | US$2.63m | 0% $ 0 | |
| Chief Regulatory Officer | 7.8yrs | US$2.57m | 0% $ 0 | |
| Chief Medical Officer | 3.4yrs | US$2.68m | 0% $ 0 | |
| Chief Accounting Officer & Controller | 11.3yrs | Nessun dato | Nessun dato | |
| Chief Scientific Officer | 7.3yrs | US$3.34m | Nessun dato | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Chief Legal Officer | no data | US$1.18m | Nessun dato | |
| Chief People Officer | less than a year | Nessun dato | Nessun dato | |
| Company Secretary | no data | Nessun dato | Nessun dato |
7.5yrs
Durata media
55yo
Età media
Gestione esperta: Il team dirigenziale di PRTA è esperto e expertise (durata media dell'incarico 7.4 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President | 8yrs | US$7.04m | 0.024% $ 256.5k | |
| Independent Director | 2.1yrs | US$896.63k | 0% $ 0 | |
| Independent Director | 11.8yrs | US$912.48k | 0.0023% $ 24.5k | |
| Independent Chairman | less than a year | Nessun dato | Nessun dato | |
| Independent Chair Emeritus | less than a year | US$923.48k | 0.00045% $ 4.9k | |
| Independent Director | 11.8yrs | US$917.26k | 0% $ 0 | |
| Independent Director | 11.2yrs | US$901.73k | 0.0078% $ 84.3k | |
| Independent Director | 5.2yrs | US$908.48k | 0% $ 0 | |
| Independent Director | 4.8yrs | Nessun dato | Nessun dato | |
| Independent Director | 1.3yrs | US$1.70m | Nessun dato |
5.0yrs
Durata media
62yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PRTA sono considerati esperti (durata media dell'incarico 4.9 anni).